Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline

By P. Raina, P. Santaguida, A. Ismaila, C. Patterson, David Cowan, Mitch Levine, L. Booker, Mark Oremus. Annals of Internal Medicine, 2008

777 citations recorded by the source corpus.

Subfields: Neurology, Pharmacology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/237f40d336e9ac97c78b5f09a2c2417039d7294d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Flavia R. Silva
2. Talita H. Ferreira-Vieira
3. F. M. Ribeiro
4. Isabella M. Guimarães

Citations in the corpus

• Genetics of Alzheimer Disease (2010, neutral): “Treatment of AD with cholinesterase inhibitors and memantine may result in slowing of cognitive decline in patients with mildto-moderate dementia, but current treatments do not modify the course of illness.(11,12)”
• Alzheimer's Disease: Targeting the Cholinergic System (2016, background): “1016/S0006-8993(02)03262-6 [234] Raina, P.”